HIF1A and ulcerative colitis: In 2021, Lu and colleagues revealed a novel mechanism of cyclosporine A in alleviating acute severe ulcerative colitis (ASUC) by promoting neutrophil HIF-1α expression and restricting excessive neutrophil activation in the SIRT6-HIF-1α-glycolysis axis (Figure 4) [104].